Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2019-04-08 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/03/2019. The content focuses on share capital changes and confirmations related to securities issuance. There is no indication of financial performance data, management discussion, earnings, or audit information. The document is a regulatory filing reporting share capital movements to the stock exchange, consistent with a Major Shareholding Notification or Share Issue/Capital Change. Given the detailed reporting of share capital movements and no mention of voting results or director dealings, the best fit is Share Issue/Capital Change (SHA). The document length is substantial and contains detailed data, not just an announcement or certification, so it is not RPA or RNS. Therefore, the classification is SHA with high confidence.
2019-04-08 English
CONTINUING CONNECTED TRANSACTIONS UNDER THE SERVICE AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement by CMBC Capital Holdings Limited regarding continuing connected transactions under a service agreement with CMBCI. It details the terms, pricing, internal controls, and regulatory compliance related to asset management, underwriting referral, and distribution services. The content focuses on contractual and regulatory disclosures about ongoing business arrangements rather than financial results, management changes, or legal proceedings. It is a regulatory announcement about connected transactions under listing rules, typical of a Regulatory Filings (RNS) category. The document is lengthy (15,000 characters) and contains detailed disclosures but does not present financial statements or earnings data, nor is it a report or presentation. Therefore, the best classification is Regulatory Filings (RNS).
2019-04-04 English
EXPECTED PAYMENT DATE OF FINAL DIVIDEND
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding the expected payment date of the final dividend for the year ended 31 December 2018. It references a prior annual results announcement and details the dividend payment schedule and shareholder register closure dates. The document is short (2556 characters) and focuses solely on dividend payment information without containing financial statements or detailed financial analysis. It is not the dividend declaration itself but an announcement about the payment date and related administrative details. Therefore, it fits best under the category of Notice of Dividend Amount (DIV).
2019-03-29 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018' and contains detailed consolidated financial statements including profit or loss, comprehensive income, statement of financial position, notes on basis of preparation, application of new accounting standards (HKFRS 9 and HKFRS 15), and detailed financial data for the full fiscal year ending 31 December 2018. The length is substantial (15,000 characters) and it includes actual financial data and analysis, not just an announcement or summary. This matches the characteristics of an Annual Report (10-K equivalent) rather than a short earnings release or announcement. Therefore, the document should be classified as an Annual Report (10-K).
2019-03-28 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF REDEMPTION OF SHARES IN SEGREGATED PORTFOLIO
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by CMBC Capital Holdings Limited regarding the completion of redemption of shares in a segregated portfolio. It references previous announcements and a circular but primarily informs about the repayment of a loan and the redemption of shares. The document is relatively short (2636 characters) and serves as an update on a specific financing event rather than a full financial report or detailed financial data. It does not contain financial statements or detailed analysis but rather a status update on capital structure related to share redemption and loan repayment. Therefore, it fits best under Capital/Financing Update (CAP).
2019-03-18 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from CMBC Capital Holdings Limited stating the date of a board meeting to consider and approve the consolidated annual results for the year ended 31 December 2018 and the recommendation of a final dividend. It does not contain any financial data or the actual annual results, but merely announces the upcoming board meeting and the intention to publish results. The document length is only 1452 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such short announcements about the timing of report publication or board meetings related to results are classified as Regulatory Filings (RNS).
2019-03-15 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.